• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Establishing a high-titer infectious avian influenza A (H5N1) pseudotyped viral particle

tetano

Editor, Senior Moderator
Bing Du Xue Bao. 2012 Jun;28(4):324-9.
[Establishing a high-titer infectious avian influenza A (H5N1) pseudotyped viral particle].
[Article in Chinese]
Liu XJ, Guo ZP, Shen LP, Wang Y, Shi HY, Zhang GH, Zhang X, Bi SL, Zhao HL.
Source

Institute of Medical Virology, School of Laboratory Medicine and Life Science, Wenzhou Medical College, Wenzhou 325035, China. liuxijun.jack@126.com
Abstract

A transient four-plasmid cotransfection system was used to construct avian influenza A (H5N1) pseudotyped viral particle (H5N1Pp) by incorporating hemagglutinin (HA) protein and neuraminidase (NA) protein from H5N1 avian influenza virus onto Murine leukemia virus pseudotyped viral particles, the transmission electron microscopy, infectivity titer assay, hemagglutination assay, neutralization assay of H5N1Pp were studied. We established a pseudotyped H5N1 viral particle at a high titer of 10(8) Pp/mL, the morphology,the hemagglutination activity and neutralization specificity of H5N1Pp is simililar to wild H5N1 virus. The research result sets a platform for studying this virus, including its receptors, the functional analysis of HA and NA, neutralizing antibodies and anti-H5N1 drug development.

PMID:
22978154
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/22978154
 
Back
Top Bottom